BioSpace News Archive

InMed Pharmaceuticals Inc. (“InMed” or “the Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced that members of its senior scientific and clinical team will be attending the EB2020 World Congress, organized and funded by the Dystrophic Epidermolysis Bullosa Research Association (DEBRA), from January 19-23, 2020 in London, UK.

Progressive Care Inc., a personalized healthcare services and technology company, is excited to update current and prospective shareholders with the Company’s operational performance update for the month of December 2019

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”) announced today that its DNA Exam Laboratory completely built in October of 2019

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusive partnership with Fios Genomics, a leading provider of bioinformatics data analysis services.

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 98,000 shares of Geron common stock as inducements to two newly-hired employees in connection with commencement of employment with the Company.

Owens & Minor, Inc. (NYSE:OMI) announces today its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company and one of Europe’s leading providers of healthcare logistics services.

The National Association of Neonatal Nurses (NANN) released their Newborn Safe Sleep guideline, the only clinical practice guideline that addresses the challenges of and provides recommendations on implementing safe sleep practices in the hospital setting for children between birth and 1 year of age.

Major milestone in commercialization of precision medicine technology achieved

AIP Publishing is pleased to announce two new journals launching later this year.

Kevil brings global scientific expertise to advance JanOne’s drug development portfolio and advise on upcoming Phase 2b clinical trials for PAD